Emerging role of berbamine as an anti-cancer agent in systemic malignancies besides chronic myeloid leukemia
نویسندگان
چکیده
منابع مشابه
Emerging applications of argatroban in the management of systemic malignancies: potential benefits besides its primary role as an antithrombin agent.
Emerging Applications of Argatroban in the Management of Systemic Malignancies Potential Benefits Besides Its Primary Role as an Antithrombin Agent The recent article by Coppens et al provided for highly stimulating reading. Argatroban may exert several antineoplastic effects besides its antithrombin effects. Argatroban exerts significant antineoplastic effects in gliomas. Thrombin, in general,...
متن کاملThe role of microRNA in acute/chronic, myeloid/lymphocytic leukemia
MicroRNAs are small, non-coding sequences that regulate gene expression by inducing degradation or translational inhibition of target mRNAs. These molecules control many intracellular physiological and pathological processes.Abnormal expression of these moleculs has been described in different cancers including hematopoietic cancers. According to the type of cancer and the stage, miRNA’s expres...
متن کاملSkp2 and Its Emerging Role in the Pathogenesis of Systemic Malignancies Besides Breast Carcinomas
The recent article by Wang et al. (2012a) was highly interesting. Interestingly, recent data suggests that Skp2 expression may play a significant role in the etio-pathogenesis of a number of systemic malignancies besides breast carcinomas. For instance, the expression of Skp2 in prostate cancers is decreased by androgens and is mediated via pathways that are dependent on p107 as well as pathway...
متن کاملHematologic Malignancies Chronic Myeloid Leukemia
© Touch MEdical MEdia 2014 97 Abstract Chronic myeloid leukemia (CML) is induced by the BCR-ABL oncogene. The advent of BCR-ABL tyrosine kinase inhibitors (TKIs) has redefined treatment goals in CML starting with imatinib and followed by the newer TKI inhibitors including dasatinib, nilotinib, bosutinib, and ponatinib. However, a significant proportion of patients do not achieve a satisfactory ...
متن کاملsMICA and its emerging role as a prognostic and diagnostic indicator in systemic malignancies besides hepatocellular carcinoma
I read the recent article by Li . [1] with great interest. Intriguingly, emerging evidence suggests that soluble major histocompatibility complex class Irelated chain A (sMICA) may be an important diagnostic and prognostic marker in a number of systemic malignancies besides hepatocellular carcinoma. For instance, higher sMICA levels are seen in oral squamous cell carcinomas of high TNM stages ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Zhejiang University SCIENCE B
سال: 2012
ISSN: 1673-1581,1862-1783
DOI: 10.1631/jzus.b1200110